Assessing the quality of life of health-referred children and adolescents with short stature: development and psychometric testing of the QoLISSY instrument
Authors:
- Monika BullingerMBMonika Bullinger
- Julia QuitmannJulia Quitmann
- Mick PowerMPMick Power
- Michael HerdmanMHMichael Herdman
- Emmanuelle MimounEMEmmanuelle Mimoun
- Kendra DeBuskKDKendra DeBusk
- Eva FeigerlovaEFEva Feigerlova
- Carolina LundeCLCarolina Lunde
- Maria Dellenmark-BlomMDMaria Dellenmark-Blom
- Dolores SanzDSDolores Sanz
- Anja RohenkohlARAnja Rohenkohl
- Andreas PleilAPAndreas Pleil
Open Access
- 1 January 2013
- journal article
- research article
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 11 (1) , 76
Abstract
When evaluating the outcomes of treatment in paediatric endocrinology, the health-related quality of life (HrQoL) of the child is to be taken into consideration. Since few self–reported HrQoL instruments exist for children with diagnosed short stature (dSS), the objective of this study was to develop and psychometrically test a targeted HrQoL instrument for use in multinational clinical research. The target population were short stature (height < −2 SDS) children and adolescents (age 8–12 and 13–18 years) with a diagnosis of growth hormone deficiency (GHD) or idiopathic short stature (ISS), differing in growth hormone treatment status. Focus group discussions for concept and item generation, piloting of the questionnaire with cognitive debriefing, and instrument field testing with a retest were conducted simultaneously in five countries. After qualitative and preliminary quantitative analyses, psychometric testing of field test data in terms of reliability and validity including confirmatory factor analyses (CFA) was performed. Following item generation from focus group discussions, 124 items were included in a pilot test with a cognitive debriefing exercise providing preliminary feedback on item and domain operating characteristics. A field test with 268 participants showed high internal consistency reliabilities (alpha 0.82 – 0.95), good correlations with generic measures (up to r = .58), significant known group differences (e.g. in height: F = 32, df 244, p < 0.001) and an acceptable CFA model fit suggesting construct validity of the three-domain core structure with 22 items, supplemented by three mediator domains with 28 items. The QoLISSY questionnaire is a promising step forward in assessing the impact of dSS on HrQoL. It is based on items generated from the subjective experience of short stature children referred for endocrine investigation, is validated for use in five languages and it is easy to administer in clinical and research settings.Keywords
This publication has 49 references indexed in Scilit:
- Growth-Related Quality of LifeHormone Research in Paediatrics, 2011
- Health-related quality of life and cognitive functioning in pediatric short stature: comparison of growth-hormone-naïve, growth-hormone-treated, and healthy samplesEuropean Journal of Pediatrics, 2010
- Growth Hormone and Health PolicyThe Journal of Clinical Endocrinology & Metabolism, 2010
- Idiopathic Short Stature: Conundrums of Definition and TreatmentInternational Journal of Pediatric Endocrinology, 2009
- Introduction: Unresolved Issues in the Management of Children with Idiopathic Short StatureHormone Research in Paediatrics, 2009
- An evaluation of the relationship between adult height and health‐related quality of life in the general UK populationClinical Endocrinology, 2007
- The Effects of Growth Hormone Treatment on Health-Related Quality of Life in ChildrenHormone Research in Paediatrics, 2006
- Towards a Consensus on the Definition of Idiopathic Short StatureHormone Research, 1996
- Utah Growth Study: Growth standards and the prevalence of growth hormone deficiencyThe Journal of Pediatrics, 1994
- Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelinesJournal of Clinical Epidemiology, 1993